{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:42:30Z","timestamp":1773200550327,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,10,15]],"date-time":"2009-10-15T00:00:00Z","timestamp":1255564800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s12032-009-9331-8","type":"journal-article","created":{"date-parts":[[2009,10,14]],"date-time":"2009-10-14T16:33:41Z","timestamp":1255538021000},"page":"1046-1049","source":"Crossref","is-referenced-by-count":24,"title":["Frequency of TPMT alleles in Indian patients with acute lymphatic leukemia and effect on the dose of 6-mercaptopurine"],"prefix":"10.1007","volume":"27","author":[{"given":"Salamun","family":"Desire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poonkuzhali","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Bajel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biju","family":"George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Auro","family":"Viswabandya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikram","family":"Mathews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mammen","family":"Chandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,10,15]]},"reference":[{"issue":"5","key":"9331_CR1","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet. 1980;32(5):651\u201362.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"9331_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00008571-199608000-00001","volume":"6","author":"EY Krynetski","year":"1996","unstructured":"Krynetski EY, Tai HL, Yates CR, et al. Genetic polymorphism of thiopurine S-methyltransferase: clinical importance and molecular mechanisms. Pharmacogenetics. 1996;6(4):279\u201390.","journal-title":"Pharmacogenetics"},{"issue":"6","key":"9331_CR3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-199912000-00012","volume":"9","author":"HL McLeod","year":"1999","unstructured":"McLeod HL, Pritchard SC, Githang\u2019a J, et al. Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals. Pharmacogenetics. 1999;9(6):773\u20136.","journal-title":"Pharmacogenetics"},{"issue":"4","key":"9331_CR4","first-page":"694","volume":"58","author":"HL Tai","year":"1996","unstructured":"Tai HL, Krynetski EY, Yates CR, et al. Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in Caucasians. Am J Hum Genet. 1996;58(4):694\u2013702.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"9331_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.7326\/0003-4819-126-8-199704150-00003","volume":"126","author":"CR Yates","year":"1997","unstructured":"Yates CR, Krynetski EY, Loennechen T, et al. Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann Intern Med. 1997;126(8):608\u201314.","journal-title":"Ann Intern Med"},{"issue":"5","key":"9331_CR6","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1172\/JCI1004","volume":"101","author":"DM Otterness","year":"1998","unstructured":"Otterness DM, Szumlanski CL, Wood TC, Weinshilboum RM. Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. J Clin Invest. 1998;101(5):1036\u201344.","journal-title":"J Clin Invest"},{"issue":"1","key":"9331_CR7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0009-9236(97)90152-1","volume":"62","author":"D Otterness","year":"1997","unstructured":"Otterness D, Szumlanski C, Lennard L, et al. Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther. 1997;62(1):60\u201373.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"9331_CR8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.leu.2401723","volume":"14","author":"HL McLeod","year":"2000","unstructured":"McLeod HL, Krynetski EY, Relling MV, Evans WE. Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia. 2000;14(4):567\u201372.","journal-title":"Leukemia"},{"issue":"1","key":"9331_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00129785-200404010-00001","volume":"4","author":"H Corominas","year":"2004","unstructured":"Corominas H, Baiget M. Clinical utility of thiopurine S-methyltransferase genotyping. Am J Pharmacogenomics. 2004;4(1):1\u20138.","journal-title":"Am J Pharmacogenomics"},{"issue":"23","key":"9331_CR10","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/jnci\/91.23.2001","volume":"91","author":"MV Relling","year":"1999","unstructured":"Relling MV, Hancock ML, Rivera GK, et al. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus. J Natl Cancer Inst. 1999;91(23):2001\u20138.","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"9331_CR11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","volume":"85","author":"HL McLeod","year":"1995","unstructured":"McLeod HL, Relling MV, Liu Q, et al. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood. 1995;85(7):1897\u2013902.","journal-title":"Blood"},{"issue":"6","key":"9331_CR12","first-page":"567","volume":"3","author":"TL Brenner","year":"2001","unstructured":"Brenner TL, Pui CH, Evan WE. Pharmacogenomics of childhood acute lymphoblastic leukemia. Curr Opin Mol Ther. 2001;3(6):567\u201378.","journal-title":"Curr Opin Mol Ther"},{"issue":"1","key":"9331_CR13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14622416.3.1.89","volume":"3","author":"HL McLeod","year":"2002","unstructured":"McLeod HL, Siva C. The thiopurine S-methyltransferase gene locus\u2014implications for clinical pharmacogenomics. Pharmacogenomics. 2002;3(1):89\u201398.","journal-title":"Pharmacogenomics"},{"issue":"5","key":"9331_CR14","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/pbc.21671","volume":"51","author":"A Bajel","year":"2008","unstructured":"Bajel A, George B, Mathews V, et al. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer. 2008;51(5):621\u20135.","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"9331_CR15","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/sj.leu.2404785","volume":"21","author":"A Bajel","year":"2007","unstructured":"Bajel A, George B, Mathews V, et al. Adult ALL: treatment outcome and prognostic factors in an Indian population using a modified German ALL (GMALL) protocol. Leukemia. 2007;21(10):2230\u20133.","journal-title":"Leukemia"},{"issue":"7","key":"9331_CR16","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood-2008-12-193250","volume":"114","author":"M Stanulla","year":"2009","unstructured":"Stanulla M, Schaeffeler E, Moricke A, et al. Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Munster protocols. Blood. 2009;114(7):1314\u20138.","journal-title":"Blood"},{"issue":"5","key":"9331_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00043426-200206000-00006","volume":"24","author":"SK Kham","year":"2002","unstructured":"Kham SK, Tan PL, Tay AH, et al. Thiopurine methyltransferase polymorphisms in a multiracial asian population and children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 2002;24(5):353\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"9331_CR18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/8.2.367","volume":"8","author":"MM Ameyaw","year":"1999","unstructured":"Ameyaw MM, Collie-Duguid ES, Powrie RH, et al. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet. 1999;8(2):367\u201370.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9331_CR19","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00228-007-0426-x","volume":"64","author":"SK Kham","year":"2008","unstructured":"Kham SK, Soh CK, Liu TC, et al. Thiopurine S-methyltransferase activity in three major Asian populations: a population-based study in Singapore. Eur J Clin Pharmacol. 2008;64(4):373\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"9331_CR20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","volume":"9","author":"ES Collie-Duguid","year":"1999","unstructured":"Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics. 1999;9(1):37\u201342.","journal-title":"Pharmacogenetics"},{"issue":"7","key":"9331_CR21","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","volume":"14","author":"E Schaeffeler","year":"2004","unstructured":"Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics. 2004;14(7):407\u201317.","journal-title":"Pharmacogenetics"},{"issue":"2","key":"9331_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-004-0732-5","volume":"60","author":"C Ganiere-Monteil","year":"2004","unstructured":"Ganiere-Monteil C, Medard Y, Lejus C, et al. Phenotype and genotype for thiopurine methyltransferase activity in the French Caucasian population: impact of age. Eur J Clin Pharmacol. 2004;60(2):89\u201396.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"9331_CR23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/sj.tpj.6500175","volume":"3","author":"WL Boson","year":"2003","unstructured":"Boson WL, Romano-Silva MA, Correa H, et al. Thiopurine methyltransferase polymorphisms in a Brazilian population. Pharmacogenomics J. 2003;3(3):178\u201382.","journal-title":"Pharmacogenomics J"},{"issue":"8","key":"9331_CR24","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1200\/JCO.2001.19.8.2293","volume":"19","author":"WE Evans","year":"2001","unstructured":"Evans WE, Hon YY, Bomgaars L, et al. Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine. J Clin Oncol. 2001;19(8):2293\u2013301.","journal-title":"J Clin Oncol"},{"issue":"3","key":"9331_CR25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1046\/j.1365-2141.1999.01416.x","volume":"105","author":"HL McLeod","year":"1999","unstructured":"McLeod HL, Coulthard S, Thomas AE, et al. Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia. Br J Haematol. 1999;105(3):696\u2013700.","journal-title":"Br J Haematol"},{"issue":"4","key":"9331_CR26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.bjp.0702152","volume":"125","author":"C Spire-Vayron de la Moureyre","year":"1998","unstructured":"Spire-Vayron de la Moureyre C, Debuysere H, Mastain B, et al. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br J Pharmacol. 1998;125(4):879\u201387.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"9331_CR27","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1001\/jama.293.12.1485","volume":"293","author":"M Stanulla","year":"2005","unstructured":"Stanulla M, Schaeffeler E, Flohr T, et al. Thiopurine methyltransferase (TPMT) genotype and early treatment response to mercaptopurine in childhood acute lymphoblastic leukemia. Jama. 2005;293(12):1485\u20139.","journal-title":"Jama"},{"issue":"12","key":"9331_CR28","first-page":"929","volume":"41","author":"XL Ma","year":"2003","unstructured":"Ma XL, Zhu P, Wu MY, et al. Relationship between single nucleotide polymorphisms in thiopurine methyltransferase gene and tolerance to thiopurines in acute leukemia. Zhonghua Er Ke Za Zhi. 2003;41(12):929\u201333.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"4","key":"9331_CR29","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/1096-911X(20001001)35:4<410::AID-MPO3>3.0.CO;2-R","volume":"35","author":"S Hongeng","year":"2000","unstructured":"Hongeng S, Sasanakul W, Chuansumrit A, et al. Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia. Med Pediatr Oncol. 2000;35(4):410\u20134.","journal-title":"Med Pediatr Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9331-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-009-9331-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-009-9331-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T01:17:53Z","timestamp":1590196673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-009-9331-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,15]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["9331"],"URL":"https:\/\/doi.org\/10.1007\/s12032-009-9331-8","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,15]]}}}